NO170938C - Analogifremgangsmaate for fremstilling av terapeutisk virksomme fosfonosubstituerte aminoalkensyrer - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk virksomme fosfonosubstituerte aminoalkensyrerInfo
- Publication number
- NO170938C NO170938C NO870577A NO870577A NO170938C NO 170938 C NO170938 C NO 170938C NO 870577 A NO870577 A NO 870577A NO 870577 A NO870577 A NO 870577A NO 170938 C NO170938 C NO 170938C
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- amino
- acids
- phosphonosubstituted
- aminoalky
- Prior art date
Links
- 239000002253 acid Substances 0.000 title 1
- 150000007513 acids Chemical class 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 4
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 2
- BDYHNCZIGYIOGJ-DUXPYHPUSA-N (e)-2-amino-4-methyl-5-phosphonopent-3-enoic acid Chemical compound OP(=O)(O)CC(/C)=C/C(N)C(O)=O BDYHNCZIGYIOGJ-DUXPYHPUSA-N 0.000 abstract 1
- TUMOUMLCWZEIRK-OWOJBTEDSA-N (e)-2-amino-5-phosphonopent-3-enoic acid Chemical compound OC(=O)C(N)\C=C\CP(O)(O)=O TUMOUMLCWZEIRK-OWOJBTEDSA-N 0.000 abstract 1
- OKDOWCKDTWNRCB-GQCTYLIASA-N [(e)-4-amino-5-ethoxy-2-methyl-5-oxopent-2-enyl]phosphonic acid Chemical compound CCOC(=O)C(N)\C=C(/C)CP(O)(O)=O OKDOWCKDTWNRCB-GQCTYLIASA-N 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000004183 alkoxy alkyl group Chemical group 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000001188 haloalkyl group Chemical group 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3826—Acyclic unsaturated acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
- C07F9/302—Acyclic unsaturated acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
- C07F9/32—Esters thereof
- C07F9/3205—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/3217—Esters of acyclic unsaturated acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4015—Esters of acyclic unsaturated acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Compounds Of Unknown Constitution (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH57886 | 1986-02-13 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO870577D0 NO870577D0 (no) | 1987-02-13 |
| NO870577L NO870577L (no) | 1987-08-14 |
| NO170938B NO170938B (no) | 1992-09-21 |
| NO170938C true NO170938C (no) | 1992-12-30 |
Family
ID=4190244
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO870577A NO170938C (no) | 1986-02-13 | 1987-02-13 | Analogifremgangsmaate for fremstilling av terapeutisk virksomme fosfonosubstituerte aminoalkensyrer |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP0233154B1 (hu) |
| JP (2) | JPH0717665B2 (hu) |
| KR (1) | KR900003533B1 (hu) |
| AT (1) | ATE70535T1 (hu) |
| AU (1) | AU610493B2 (hu) |
| CA (1) | CA1331625C (hu) |
| CY (1) | CY1821A (hu) |
| DD (1) | DD263775A5 (hu) |
| DE (1) | DE3775229D1 (hu) |
| DK (1) | DK169341B1 (hu) |
| ES (1) | ES2038690T3 (hu) |
| FI (1) | FI85144C (hu) |
| GR (1) | GR3003526T3 (hu) |
| HK (1) | HK95594A (hu) |
| HU (1) | HU204532B (hu) |
| IE (1) | IE59417B1 (hu) |
| IL (1) | IL81543A0 (hu) |
| NO (1) | NO170938C (hu) |
| NZ (1) | NZ219255A (hu) |
| PH (1) | PH23762A (hu) |
| PT (1) | PT84270B (hu) |
| SG (1) | SG92294G (hu) |
| ZA (1) | ZA871022B (hu) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5175344A (en) * | 1986-02-13 | 1992-12-29 | Ciba-Geigy Corporation | Unsaturated amino acids |
| PT85874B (pt) * | 1986-10-09 | 1990-07-31 | Ciba Geigy Ag | Processo para a preparacao de oligo-peptidos com accao antibiotica |
| EP0302826A3 (de) * | 1987-08-04 | 1991-04-03 | Ciba-Geigy Ag | Verfahren zur Herstellung neuer ungesättigter Aminosäureverbindungen |
| US5175153A (en) * | 1987-11-30 | 1992-12-29 | Warner-Lambert Company | Substituted alpha-amino acids having pharmaceutical activity |
| US5179085A (en) * | 1989-03-15 | 1993-01-12 | Warner-Lambert Company | N-substituted α-amino acids and derivatives thereof having pharmaceutical activity |
| ATE112282T1 (de) * | 1989-04-07 | 1994-10-15 | Ciba Geigy Ag | Ungesättigte aminodicarbonsäurederivate. |
| US5500419A (en) * | 1989-09-19 | 1996-03-19 | Merrell Dow Pharmaceuticals Inc. | NMDA antagonists |
| US5294734A (en) * | 1989-09-26 | 1994-03-15 | Ciba-Geigy Corp. | 4-substituted 2-aminoalk-3-enoic acids |
| US5488140A (en) * | 1989-09-26 | 1996-01-30 | Ciba-Geigy Corporation | 4-substituted 2-aminoalk-3-enoic |
| EP0420806B1 (de) * | 1989-09-26 | 1995-07-05 | Ciba-Geigy Ag | Phosphonsäure, Verfahren zur Herstellung und Verwendung als Arzneimittelwirkstoff |
| US5238958A (en) * | 1990-02-26 | 1993-08-24 | Warner-Lambert Company | Substituted α-amino acids having selected acidic moieties for use as excitatory amino acid antagonists in pharmaceuticals |
| JPH07505908A (ja) * | 1992-09-28 | 1995-06-29 | マックセチーニ、マリア ルイザ | Ｎｍｄａ受容体のアロステリックモジュレーター |
| JP2009511624A (ja) * | 2005-10-18 | 2009-03-19 | サーントゥル ナシオナル ドゥ ラ ルシェルシュ シャーンティフィク （セ エン エール エス） | 次亜リン酸誘導体及びその治療的用途 |
| DE102007032669A1 (de) * | 2007-07-13 | 2009-01-15 | Clariant International Limited | Alkylphosphonigsäuren, -salze und -ester, Verfahren zu deren Herstellung und ihre Verwendung |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5387314A (en) * | 1977-01-07 | 1978-08-01 | Heiichi Sakai | Nn14099substance |
| GB2104079B (en) * | 1981-08-14 | 1985-08-21 | London Polytech | New aminoacid isomers, their production and their medicinal use |
| US4477391A (en) | 1981-08-14 | 1984-10-16 | Collins James F | Amino acid isomers, their production and their medicinal use |
-
1987
- 1987-02-10 DE DE8787810080T patent/DE3775229D1/de not_active Expired - Lifetime
- 1987-02-10 AT AT87810080T patent/ATE70535T1/de not_active IP Right Cessation
- 1987-02-10 EP EP87810080A patent/EP0233154B1/de not_active Expired - Lifetime
- 1987-02-10 ES ES198787810080T patent/ES2038690T3/es not_active Expired - Lifetime
- 1987-02-11 IL IL81543A patent/IL81543A0/xx not_active IP Right Cessation
- 1987-02-11 CA CA000529448A patent/CA1331625C/en not_active Expired - Fee Related
- 1987-02-11 PT PT84270A patent/PT84270B/pt not_active IP Right Cessation
- 1987-02-11 KR KR1019870001107A patent/KR900003533B1/ko not_active IP Right Cessation
- 1987-02-11 FI FI870558A patent/FI85144C/fi not_active IP Right Cessation
- 1987-02-11 DD DD87299843A patent/DD263775A5/de not_active IP Right Cessation
- 1987-02-12 HU HU87554A patent/HU204532B/hu not_active IP Right Cessation
- 1987-02-12 JP JP62028375A patent/JPH0717665B2/ja not_active Expired - Lifetime
- 1987-02-12 ZA ZA871022A patent/ZA871022B/xx unknown
- 1987-02-12 DK DK070787A patent/DK169341B1/da not_active IP Right Cessation
- 1987-02-12 IE IE36587A patent/IE59417B1/en not_active IP Right Cessation
- 1987-02-12 NZ NZ219255A patent/NZ219255A/xx unknown
- 1987-02-12 AU AU68726/87A patent/AU610493B2/en not_active Ceased
- 1987-02-13 PH PH34860A patent/PH23762A/en unknown
- 1987-02-13 NO NO870577A patent/NO170938C/no unknown
-
1992
- 1992-01-08 GR GR910402040T patent/GR3003526T3/el unknown
-
1994
- 1994-07-11 SG SG92294A patent/SG92294G/en unknown
- 1994-09-01 JP JP6208837A patent/JP2509465B2/ja not_active Expired - Lifetime
- 1994-09-08 HK HK95594A patent/HK95594A/xx not_active IP Right Cessation
-
1995
- 1995-10-20 CY CY182195A patent/CY1821A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO170938C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme fosfonosubstituerte aminoalkensyrer | |
| ES2057126T3 (es) | Metodo de tratamiento de la caquexia y algunos nuevos compuestos para utilizar en este metodo. | |
| HUP9701540A1 (hu) | A gasztrointesztinális keringést elősegítő gyógyászati készítmény | |
| ES2058173T3 (es) | Dioxialquilenaril-dihidropiridinas, productos intermedios para su fabricacion, procedimientos para su fabricacion y su utilizacion. | |
| DK132188D0 (da) | Anvendelse af tetrahydrobenz(c,d)indol-6-carboxamider som anxiolytika | |
| PT88383A (pt) | Verfahren fuer die herstellung von 2-[4-<2-(4-chlorbenzamido)-ethyl-phenoxy]-2-methylpropionsaeure enthaltenden pharmazeutischen zusammensetzungen zur behandlung von diabetes geeignet | |
| FI853254A0 (fi) | Foerfarande foer framstaellning av nya steroider, vilka aer substituerade i 10-staellningen med en radikal innehaollande en dubbel- eller tredubbelbindning. | |
| DE3787796T2 (de) | Anwendung heterozyklischer Derivate zur Herstellung von Arzneimitteln. | |
| ATE100439T1 (de) | 2-(2-hydroxy-3-phenoxypropylamino)-ethoxybenzol derivate. | |
| ATE62684T1 (de) | Hydroxyindolester. | |
| DE3882956D1 (de) | Gegen die zerebrale insuffizienz wirksame verbindungen. | |
| FR2244489A1 (en) | 3-Halo-4-heterocyclic substd.-phenylalkanoic acids - their esters and salts with antiinflammatory activity | |
| SE8204641L (sv) | Aminosyraderivat | |
| HUP0000414A2 (hu) | Új pentaeritritszármazékok, előállításuk, alkalmazásuk és intermedierjeik | |
| SU681818A1 (ru) | Эфиры α-триалкилсилоксикарбоновых кислот, проявляющие анальгетическую или пролонгирующую гексеналовый наркоз активность | |
| ATE144257T1 (de) | Tetrahydro-4-phenylimino-3-thiophenessigsäuren | |
| DE58909563D1 (de) | 3-Anilino-2-hydroxycarbonyl-4-thiophenessigsäuren | |
| PT80187A (en) | A process for the preparation of quinoline carboxylic acid derivatives |